America’s AI Boom Has a Trade Policy Blind Spot
The AI data center buildout has exposed three distinct failures in U.S. trade and industrial policy.
On Capitol Hill, China Themes Increasingly Center On Trade Theft, Espionage, IP Violations
How did China become a near peer competitor with the U.S. on everything from computers to AI platforms to space? Theft and IP violations.
CPA Warns of Critical U.S. Vulnerabilities in Antibiotic Supply Chain, Calls for Action to Protect and Rebuild Domestic and Allied Production
Without secure upstream API and 6-APA production, the United States does not have true antibiotic supply security. With the right policy framework and close coordination with European partners, we can rebuild domestic capacity, strengthen allied production, and secure essential medicines for the long term.
In Hearing, Congress Says China Stealing American AI Models, But Witnesses Focus On More Obvious Problems
Leadership of the House Select Committee on the CCP is convinced China is stealing American AI models. That’s why China has an OpenAI rival, called DeepSeek, and the Europeans have nothing.
War, AI, and Grid Stress: Why This Is Solar Power’s Moment
The war in Iran is solar power’s Covid moment.
Warnings Of China Taking Lead In Biopharma Future In Latest Senate Hearing
China holds a rapidly expanding position in the global biologics and biosimilars market, driven by heavy government support, regulatory reforms, and massive investments in biotech hubs like Shanghai and Suzhou.
CPA Submits Comments to USITC on China’s Permanent Normal Trade Relations
Revoking PNTR for China would move Chinese imports onto an average effective Column 2 tariff rate of 38.9 percent, helping rebalance trade, restore domestic production capacity, and reduce strategic dependence on an increasingly adversarial economic system.
CPA Applauds FDA Proposal to Strengthen U.S. Generic Drug Manufacturing and Supply Chain Integrity
CPA welcomes new proposals from the Food and Drug Administration (FDA) aimed at rebuilding domestic generic drug manufacturing, strengthening oversight of foreign pharmaceutical production, and improving supply chain transparency.
New CPA Report Shows Domestic Manufacturing Market Share Rebounds in 2025 as Tariffs Begin to Reshape U.S. Industry
The report finds that the CPA Domestic Market Share Index (DMSI) – which measures the share of U.S. demand served by domestic producers – rebounded in 2025 as Section 232 tariffs and other industrial policies began to reshape the competitive landscape for American industry.
CPA Applauds Suniva’s Major U.S. Solar Cell Manufacturing Investment
Suniva’s expansion highlights the critical importance of rebuilding the domestic crystalline silicon photovoltaic (PV) supply chain—particularly solar cell manufacturing, one of the most strategically important segments of U.S. energy production.
